Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

This study has been withdrawn prior to enrollment.
(CALGB 81003 closed about a week after it was activated because of withdrawal of support. No patients were registered on this study.)
Information provided by:
Alliance for Clinical Trials in Oncology Identifier:
First received: November 15, 2011
Last updated: April 4, 2013
Last verified: August 2012
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)